Amgen files for FDA approval of Blincyto for pediatric Ph-negative B-cell precursor ALL March 3, 2016
Sellas' WT1 cancer vaccine awarded U.S. orphan drug designation for malignant pleural mesothelioma March 1, 2016
Heat Biologics updates progress of phase II trial of HS-410 for non-muscle invasive bladder cancer Feb. 29, 2016